Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer

被引：0

作者：

Paolo Peterlongo

Gisella Figlioli

Andrew J. Deans

Fergus J. Couch

机构：

[1] IFOM – The FIRC Institute for Molecular Oncology,Genome Diagnostics Program

[2] St Vincent’s Institute,Genome Stability Unit

[3] Fitzroy,Departments of Health Sciences Research

[4] Laboratory Medicine and Pathology,undefined

[5] and Oncology,undefined

[6] Mayo Clinic,undefined

来源：

npj Breast Cancer | / 7卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

FANCM protein truncating variants (PTVs) are emerging as risk factors for ER-negative and triple negative breast cancer. Here, we discuss evidence that greatest risk associates with PTVs, such as p.Arg658*, that extensively truncate the 2048 amino acid FANCM protein. Moreover, risks associated with other less-truncating FANCM PTVs such as p.Gln1701* and p.Gly1906Alafs12* may be amplified by additional gene variants acting as modifiers. Further studies need to be conducted taking into considerations these aspects.

引用

共 50 条

[1] Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer COMMENT
Peterlongo, Paolo
Figlioli, Gisella
Deans, Andrew J.
Couch, Fergus J.
[J]. NPJ BREAST CANCER, 2021, 7 (01)
[2] The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Figlioli, Gisella
Bogliolo, Massimo
Catucci, Irene
Caleca, Laura
Viz Lasheras, Sandra
Pujol, Roser
Kiiski, Johanna, I
Muranen, Taru A.
Barnes, Daniel R.
Dennis, Joe
Michailidou, Kyriaki
Bolla, Manjeet K.
Leslie, Goska
Aalfs, Cora M.
Adank, Muriel A.
Adlard, Julian
Agata, Simona
Cadoo, Karen
Agnarsson, Bjarni A.
Ahearn, Thomas
Aittomaki, Kristiina
Ambrosone, Christine B.
Andrews, Lesley
Anton-Culver, Hoda
Antonenkova, Natalia N.
Arndt, Volker
Arnold, Norbert
Aronson, Kristan J.
Arun, Banu K.
Asseryanis, Ella
Auber, Bernd
Auvinen, Paivi
Azzollini, Jacopo
Balmana, Judith
Barkardottir, Rosa B.
Barrowdale, Daniel
Barwell, Julian
Freeman, Laura E. Beane
Beauparlant, Charles Joly
Beckmann, Matthias W.
Behrens, Sabine
Benitez, Javier
Berger, Raanan
Bermisheva, Marina
Blanco, Amie M.
Blomqvist, Carl
Bogdanova, Natalia, V
Bojesen, Anders
Bojesen, Stig E.
Bonanni, Bernardo
[J]. NPJ BREAST CANCER, 2019, 5 (1)
[3] The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Gisella Figlioli
Massimo Bogliolo
Irene Catucci
Laura Caleca
Sandra Viz Lasheras
Roser Pujol
Johanna I. Kiiski
Taru A. Muranen
Daniel R. Barnes
Joe Dennis
Kyriaki Michailidou
Manjeet K. Bolla
Goska Leslie
Cora M. Aalfs
Muriel A. Adank
Julian Adlard
Simona Agata
Karen Cadoo
Bjarni A. Agnarsson
Thomas Ahearn
Kristiina Aittomäki
Christine B. Ambrosone
Lesley Andrews
Hoda Anton-Culver
Natalia N. Antonenkova
Volker Arndt
Norbert Arnold
Kristan J. Aronson
Banu K. Arun
Ella Asseryanis
Bernd Auber
Päivi Auvinen
Jacopo Azzollini
Judith Balmaña
Rosa B. Barkardottir
Daniel Barrowdale
Julian Barwell
Laura E. Beane Freeman
Charles Joly Beauparlant
Matthias W. Beckmann
Sabine Behrens
Javier Benitez
Raanan Berger
Marina Bermisheva
Amie M. Blanco
Carl Blomqvist
Natalia V. Bogdanova
Anders Bojesen
Stig E. Bojesen
Bernardo Bonanni
[J]. npj Breast Cancer, 5
[4] Prevention of ER-Negative Breast Cancer
Li, Yuxin
Brown, Powel H.
[J]. CANCER PREVENTION II, 2009, 181 : 121 - 134
[5] Prevention of ER-negative breast cancer
Brown, P. H.
[J]. EJC SUPPLEMENTS, 2008, 6 (03): : 22 - 22
[6] Targeting the mTOR/TORC Pathway for the prevention of er-negative and triple-negative breast cancer
Mazumdar, Abhijit
Hill, Jamal
Zhang, Yun
Bollu, Lakshmi Reddy
Contreras, Alejandro
Savage, Michelle
Sei, Shizuko
Mohammed, Altaf
Brown, Powel
[J]. CANCER RESEARCH, 2019, 79 (13)
[7] The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases
Figlioli, Gisella
Kvist, Anders
Tham, Emma
Soukupova, Jana
Kleiblova, Petra
Muranen, Taru A.
Andrieu, Nadine
Azzollini, Jacopo
Balmana, Judith
Barroso, Alicia
Benitez, Javier
Bertelsen, Birgitte
Blanco, Ana
Bonanni, Bernardo
Borg, Ake
Brunet, Joan
Calistri, Daniele
Calvello, Mariarosaria
Chvojka, Stepan
Cortesi, Laura
Darder, Esther
Del Valle, Jesus
Diez, Orland
Eon-Marchais, Severine
Fostira, Florentia
Gensini, Francesca
Houdayer, Claude
Janatova, Marketa
Kiiski, Johanna, I
Konstantopoulou, Irene
Kubelka-Sabit, Katerina
Lazaro, Conxi
Lesueur, Fabienne
Manoukian, Siranoush
Marcinkute, Ruta
Mickys, Ugnius
Moncoutier, Virginie
Myszka, Aleksander
Tu Nguyen-Dumont
Nielsen, Finn Cilius
Norvilas, Rimvydas
Olah, Edith
Osorio, Ana
Papi, Laura
Peissel, Bernard
Peixoto, Ana
Plaseska-Karanfilska, Dijana
Pocza, Timea
Rossing, Maria
Rudaitis, Vilius
[J]. CANCERS, 2020, 12 (02)
[8] Sex Hormones and Risk of Estrogen Receptor (ER)-Positive and ER-Negative Breast Cancer
Farhat, G. N.
Cummings, S. R.
Parimi, N.
Huang, A.
Cauley, J. A.
Rohan, T. E.
Hubbell, F. A.
Vitolins, M.
Manson, J. E.
Chlebowski, R. T.
Lee, J.
[J]. CANCER RESEARCH, 2009, 69 (24) : 533S - 533S
[9] Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
Anna E. M. Bastiaansen
A. Mieke Timmermans
Marcel Smid
Carolien H. M. van Deurzen
Esther S. P. Hulsenboom
Wendy J. C. Prager-van der Smissen
Renée Foekens
Anita M. A. C. Trapman-Jansen
Peter A. E. Sillevis Smitt
Theo M. Luider
John W. M. Martens
Martijn M. vanDuijn
[J]. Scientific Reports, 10
[10] Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
Bastiaansen, Anna E. M.
Timmermans, A. Mieke
Smid, Marcel
van Deurzen, Carolien H. M.
Hulsenboom, Esther S. P.
Prager-van der Smissen, Wendy J. C.
Foekens, Renee
Trapman-Jansen, Anita M. A. C.
Sillevis Smitt, Peter A. E.
Luider, Theo M.
Martens, John W. M.
vanDuijn, Martijn M.
[J]. SCIENTIFIC REPORTS, 2020, 10 (01)

← 1 2 3 4 5 →